secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001628280-22-012666
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ApolloMed Q1 revenue up 50% to $263M; raises FY guidance; appoints new CFO
--------------------------------------------------------------------------

- Q1 revenue $263.3M, up 50% YoY; net income attributable to ApolloMed $14.3M (+8%); adj. EBITDA $38.2M (+25%).
- FY guidance raised: revenue $1,055M–$1,085M; adj. EBITDA $136M–$166M (previous low $130M).
- CFO Eric Chin steps down for personal reasons; Chan Basho appointed Interim CFO and Chief Strategy Officer.
- Basho's compensation: $300k base, $200k sign-on bonus, $1.2M initial restricted stock award.
- Completed acquisition of Jade Health Care Medical Group, adding ~13,000 Medicare/Medicaid members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/0001628280-22-012666-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000162828022012666/ameh-20220505.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-012666

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer